canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet

RxCUI: 1811010
RxNorm name: canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet
Display name: canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet
Full name: canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INVOKAMET	CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	Janssen Pharmaceuticals, Inc.	6868666b-c25e-40d1-9d1f-306bbe9390c1	2025-08-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1811010

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6868666b-c25e-40d1-9d1f-306bbe9390c1	canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet	PSN	31	These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014	20250821
6868666b-c25e-40d1-9d1f-306bbe9390c1	canagliflozin 50 MG / metformin hydrochloride 500 MG 24HR Extended Release Oral Tablet	SY	31	These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014	20250821
6868666b-c25e-40d1-9d1f-306bbe9390c1	24 HR canagliflozin 50 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet	SCD	31	These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014	20250821